Biofrontera Inc. Form 8-K Summary
Reporting date: March 2, 2022; filed March 8, 2022. The filing reports corporate governance and executive compensation matters under Item 5.02 and includes related exhibits under Item 9.01.
Business Context and Reporting Period
Biofrontera Inc. is a Delaware corporation whose common stock and warrants trade on Nasdaq under the symbols BFRI and BFRIW. The filing is not an earnings report and does not provide financial statements or operating results for a reporting period.
Key Financial and Compensation Information
- No revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics are disclosed in the filing.
- Kevin D. Weber was appointed to the Board after the Board increased its size from four to five directors. He will serve as a Class II director through the annual meeting for fiscal year 2023.
- Mr. Weber will receive a $35,000 annual non-employee director retainer, prorated for the remainder of 2022. Additional retainers may apply if he is appointed to Board committees.
- Hermann Lübbert’s employment agreement was amended effective December 15, 2021. He is required to devote 100% of his working capacity to his duties as Executive Chairman.
- Mr. Lübbert’s annual base salary is $468,500, with eligibility for a cash bonus of up to 65% of base salary based on performance goals established in advance by the Board. No bonus is payable if achievement is below 70% of the applicable target.
Material Changes, Outlook, and Risks
- The principal changes are the addition of a director and the amendment of the Executive Chairman’s employment agreement.
- The filing provides no management guidance, business outlook, material risk update, contingency disclosure, or unusual operating item.
- Mr. Weber reported no related-party transaction requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Points
- Review Exhibit 10.1 for the complete terms of the amended employment agreement.
- Verify the final amount of any performance bonus paid to Mr. Lübbert and the performance targets used by the Board.
- Confirm whether Mr. Weber is later appointed to any Board committees and becomes eligible for additional retainers.
- Use the company’s subsequent periodic filings for financial results, liquidity, debt, guidance, and operating risks, which are not provided here.